My Pitch: "Huge potential:

Protalix's development pipeline consists of proprietary versions of recombinant therapeutic proteins that target established pharmaceutical markets, including the following product candidates: pegunigalsidase alfa, a modified version of the recombinant human a–Galactosidase–A prot"

My Pitch: "Bought"

My Pitch: "W"

My Pitch: "Going up today share prices will increase"

My Pitch: "102"

My Pitch: "Long hold"

My Pitch: "......"